Mochida Pharmaceutical Co.,Ltd. Logo

Mochida Pharmaceutical Co.,Ltd.

Develops and sells pharmaceuticals, healthcare products, and medical devices.

4534 | T

Overview

Corporate Details

ISIN(s):
JP3922800002
LEI:
Country:
Japan
Address:
新宿区四谷一丁目7番地

Description

Mochida Pharmaceutical Co., Ltd. is a research-driven company focused on the development, manufacturing, and sale of pharmaceuticals, healthcare products, and medical devices. The company's core pharmaceutical business concentrates on therapeutic areas such as cardiovascular diseases, with a key focus on circulatory agents. It is also active in other fields, including oncology, through partnerships for generic products. In its healthcare segment, Mochida develops and markets functional, low-irritating products based on dermatological science. Additionally, the company distributes medical instruments and equipment for diagnostic and surgical applications, contributing to a broad spectrum of medical care.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2018-11-09 01:33
四半期報告書-第81期第2四半期(2018/07/01-2018/09/30)
Japanese 244.5 KB
2018-08-10 02:33
四半期報告書-第81期第1四半期(2018/04/01-2018/06/30)
Japanese 206.3 KB
2018-06-28 06:37
有価証券報告書-第80期(平成29年4月1日-平成30年3月31日)
Japanese 845.5 KB
2018-02-09 01:32
四半期報告書-第80期第3四半期(2017/10/01-2017/12/31)
Japanese 206.3 KB
2017-11-10 01:17
四半期報告書-第80期第2四半期(2017/07/01-2017/09/30)
Japanese 236.8 KB
2017-08-10 02:30
四半期報告書-第80期第1四半期(2017/04/01-2017/06/30)
Japanese 169.1 KB
2017-06-29 06:30
有価証券報告書-第79期(2016/04/01-2017/03/31)
Japanese 843.2 KB
2017-02-10 01:17
四半期報告書-第79期第3四半期(2016/10/01-2016/12/31)
Japanese 176.5 KB
2016-11-10 01:20
四半期報告書-第79期第2四半期(2016/07/01-2016/09/30)
Japanese 207.0 KB
2016-08-10 02:18
四半期報告書-第79期第1四半期(2016/04/01-2016/06/30)
Japanese 168.9 KB
2016-06-29 06:08
有価証券報告書-第78期(2015/04/01-2016/03/31)
Japanese 851.9 KB
2016-02-10 01:37
四半期報告書-第78期第3四半期(2015/10/01-2015/12/31)
Japanese 178.5 KB
2015-11-11 01:31
四半期報告書-第78期第2四半期(2015/07/01-2015/09/30)
Japanese 205.0 KB

Automate Your Workflow. Get a real-time feed of all Mochida Pharmaceutical Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Mochida Pharmaceutical Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Mochida Pharmaceutical Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.